Cognitive behavioral treatment focused on positive memories for post-traumatic stress in intimate partner violence

Not Applicable

• Conditions: Treatment of posttraumatic stress symptoms in female intimate partner violence survivors.; Mental and Behavioural Disorders

• Registration Number: ISRCTN73702156
• Lead Sponsor: Complutense University of Madrid

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35870999/ (added 25/07/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-10
• Last Update Posted: 8 May 2023
• Study Completion: 2024-04-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 103

Inclusion Criteria

1. Participants must all be women
2. Participants must be over 18 years old.
3. Participants must be proficient in the use of the Spanish language
4. Participants must be victims of gender-based intimate partner violence.
5. Participants must have endure said violence at least one month before the start of the trial.
6. Participants show absence of suicide risk. Suicide risk is assessed using a Likert-type question in the screening in the last two weeks (item 9 of the Spanish version of the Beck Depression Inventory II – BDI-II; Beck et al., 1996 –). The person will match the criteria for inclusion whenever the answers given are option 0 (I do not consider committing suicide”) or 1 (I have thought about committing suicide but I’m not willing to go through with it”).
7. Participants must present PTSD according to DSM-5 criteria. PTSD symptoms and trauma history were assessed using the Global Assessment of Posttraumatic Stress Scale 5 (EGEP-5; in Spanish: Evaluación Global de Estrés Postraumático – 5; Crespo et al., 2017).
8. Participants must have agreed to take part in the study voluntarily.

Exclusion Criteria

1. The participant suffers from physical or mental conditions or has any other limitation (illiteracy, disability, etc.) that further complicates her participation in evaluation or treatment sessions.
2. The participant has been diagnosed or suffers from psychotic disorders
3. The participant is currently receiving or has received psychological treatment over the last 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Posttraumatic stress symptoms and PTSD diagnosis are measured using the Global Posttraumatic Stress Evaluation 5 (Evaluación Global de Estrés Postraumático 5 -EGEP-5) (Crespo et al., 2017) at Pre-treatment; Post-treatment assessment: to be performed in the first 14 days, after the last treatment session; Follow-up 3 months; Follow-up 6 months; and Follow-up 12 months.